ATRIUM THERAPEUTICS INC (RNA) Stock Income Statement
NASDAQ:RNA • US04965N1046
Current stock price
13.37 USD
-0.18 (-1.33%)
At close:
13.37 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.62M | 10.90M | 9.76M | 9.22M | 9.33M | |||
| Operating Expenses | 68.25M | 24.11M | 16.15M | 188.14M | 127.38M | |||
| Research and Development | 44.27M | 19.20M | 12.65M | 150.40M | 101.18M | |||
| Selling, General, and Administrative Expenses | 23.98M | 4.92M | 3.50M | 37.73M | 26.20M | |||
| Operating Income | -49.63M | -13.22M | -6.39M | -178.91M | -118.05M | |||
| Interest Income/Expense | N/A | 56.88M | 23.97M | 4.98M | 100.00K | |||
| Other Income/Expense | -12.00K | 2.00K | 1.00K | -60.00K | -60.00K | |||
| Income Before Taxes | -49.64M | -13.22M | -6.38M | -174.00M | -118.01M | |||
| Income Tax | -142.00K | 11.91M | 0.00 | N/A | N/A | |||
| Net Income | -49.50M | -25.12M | -6.38M | -174.00M | -118.01M | |||
| EBITDA | -49.31M | -13.05M | -6.25M | -177.52M | -117.41M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.89 | -1.47 | -0.37 | -3.34 | -2.85 | |||
| Non GAAP EPS | N/A | -2.89 | -2.90 | -3.33 | -2.84 | |||
| Statistics | ||||||||
| Profit Margin | -265.88% | -230.54% | -65.39% | -1887.20% | -1264.84% | |||
| Operating Profit Margin | -266.58% | -121.30% | -65.40% | -1940.46% | -1265.27% | |||
All data in USD